EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 48 filers reported holding EVELO BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $40,612 | -82.7% | 224,904 | +54.0% | 0.00% | – |
| Q4 2022 | $235,155 | +135.2% | 146,059 | +206.4% | 0.00% | – |
| Q3 2022 | $100,000 | +75.4% | 47,673 | +74.6% | 0.00% | – |
| Q2 2022 | $57,000 | -93.7% | 27,300 | -89.7% | 0.00% | – |
| Q1 2022 | $899,000 | -35.3% | 265,254 | +15.8% | 0.00% | – |
| Q4 2021 | $1,390,000 | -0.3% | 229,000 | +15.6% | 0.00% | – |
| Q3 2021 | $1,394,000 | +86.4% | 198,100 | +263.5% | 0.00% | – |
| Q2 2021 | $748,000 | +40.1% | 54,500 | +9.3% | 0.00% | – |
| Q1 2021 | $534,000 | +761.3% | 49,873 | +320.6% | 0.00% | – |
| Q3 2020 | $62,000 | – | 11,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 3,063,505 | $37,038,000 | 14.47% |
| Mayo Clinic | 484,953 | $5,863,000 | 7.05% |
| Flagship Pioneering Inc. | 22,900,069 | $276,862,000 | 5.04% |
| Trustees of Columbia University in the City of New York | 113,850 | $1,376,000 | 1.84% |
| Alphabet Inc. | 1,060,495 | $12,821,000 | 0.62% |
| Artal Group S.A. | 700,000 | $8,463,000 | 0.18% |
| Larson Financial Group LLC | 28,353 | $343,000 | 0.12% |
| PEDDOCK CAPITAL ADVISORS, LLC | 3,663 | $44,000 | 0.02% |
| CREDIT SUISSE AG/ | 2,705,511 | $32,710,000 | 0.02% |
| FMR LLC | 6,803,365 | $82,253,000 | 0.01% |